Subscribe to Updates for Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

Stay informed about the latest developments in this trial. By subscribing, you will receive updates directly to your email. These updates will provide you with important information regarding any changes or progress related to the trial.

Tell us a little bit about yourself

Please fill in the form below for the person who would like to stay in touch.

Fields marked with asterisk (*) are mandatory.